EDGAR Filing Documents for 0001618835-20-000081

Form 8-K - Current report:

SEC Accession No. 0001618835-20-000081

Filing Date

2020-04-27

Accepted

2020-04-27 08:00:41

Documents

Period of Report

2020-04-23

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	evfm8-kbakerbros.htm	8-K	78613
2	EXHIBIT 4.1	exhibit41formofwarrant2020.htm	EX-4.1	106165
3	EXHIBIT 10.1	exhibit101securitiespurcha.htm	EX-10.1	297170
4	EXHIBIT 10.2	exhibit102ipsecurityagreem.htm	EX-10.2	26428
5	EXHIBIT 10.3	exhibit103formofnote2020ba.htm	EX-10.3	22103
6	EXHIBIT 10.4	exhibit104formofregistrati.htm	EX-10.4	104682
7	EXHIBIT 99.1	exhibit991bakerbrospressre.htm	EX-99.1	14473
8		evofembiosciencesjpegfilea36.jpg	GRAPHIC	61097
	Complete submission text file	0001618835-20-000081.txt		735199

Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130

Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900

Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)